Delivery Order SPE2DR25D1021-SPE2DR26FNS4B
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On January 29, 2026, the Defense Logistics Agency awarded a $14,450.24 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The award was made on a non-set-aside, fully competitive basis, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $13,876.60 to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by January 29, 2026. The award supports the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) awarded a $4,614.37 delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials on January 28, 2026, with completion scheduled for January 29, 2026. This non-set-aside contract utilizes firm fixed-price pricing and represents a single pharmaceutical delivery to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $12,974.50 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract, executed on January 6, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is a non-set-aside procurement, indicating it was awarded through full and open competition. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,134.65 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This firm fixed-price, non-set-aside delivery order was awarded on January 6, 2026, with a completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used primarily for rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a delivery order valued at $7,257.71 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on January 21, 2026, with completion scheduled for January 22, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency awarded a delivery order valued at $11,954.98 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by January 22, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a $4,822.16 delivery order to AmerisourceBergen Drug Corp for Actemra 162 mg/0.9 mL syringes on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement designated SPE2DX and running through December 2026. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $16,453.58. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and no set-aside designation was used in the award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...